Skip to main navigation Skip to search Skip to main content

Lanadelumab

Translated title of the contribution: Lanadelumab - Trade name: Takhzyro®

Andreas Recke*

*Corresponding author for this work
Translated title of the contributionLanadelumab - Trade name: Takhzyro®
Original languageGerman
JournalInternistische Praxis
Volume62
Issue number2
Pages (from-to)358-364
Number of pages7
ISSN0020-9570
Publication statusPublished - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this